Neuropeptide Y signaling in the central nucleus of amygdala regulates alcohol-drinking and anxiety-like behaviors of alcohol-preferring rats - PubMed (original) (raw)
Neuropeptide Y signaling in the central nucleus of amygdala regulates alcohol-drinking and anxiety-like behaviors of alcohol-preferring rats
Huaibo Zhang et al. Alcohol Clin Exp Res. 2010.
Abstract
Background: The neuropeptide Y (NPY) system of the central nucleus of amygdala (CeA) has been shown to be involved in anxiety and alcoholism. In this study, we investigated the molecular mechanisms by which NPY in the CeA regulates anxiety and alcohol drinking behaviors using alcohol-preferring (P) rats as an animal model.
Methods: Alcohol-preferring rats were bilaterally cannulated targeting the CeA and infused with artificial cerebrospinal fluid (aCSF) or NPY. Alcohol drinking and anxiety-like behaviors were assessed by the 2-bottle free-choice paradigm and light/dark box (LDB) exploration test, respectively. The levels of NPY and related signaling proteins were determined by the gold immunolabeling procedure. The mRNA levels of NPY were measured by in situ RT-PCR. Double-immunofluorescence labeling was performed to observe the colocalization of NPY and Ca(2+)/calmodulin-dependent protein kinase IV (CaMK IV).
Results: We found that NPY infusion into the CeA produced anxiolytic effects, as measured by the LDB exploration test, and also decreased alcohol intake in P rats. NPY infusion into the CeA significantly increased levels of CaMK IV and phosphorylated cAMP responsive element-binding (pCREB) protein and increased mRNA and protein levels of NPY, but produced no changes in protein levels of CREB or the catalytic alpha-subunit of protein kinase A (PKA-Calpha) in the CeA. We also observed that alcohol intake produced anxiolytic effects in P rats in the LDB test and also increased NPY expression and protein levels of pCREB and PKA-Calpha without modulating protein levels of CREB or CaMK IV, in both the CeA and medial nucleus of amygdala. In addition, we found that CaMK IV-positive cells were co-localized with NPY in amygdaloid structures of P rats.
Conclusions: These results suggest that NPY infusion may increase the expression of endogenous NPY in the CeA, which is most likely attributable to an increase in CaMK IV-dependent CREB phosphorylation and this molecular mechanism may be involved in regulating anxiety and alcohol drinking behaviors of P rats.
Figures
Figure 1
Representative photomicrographs of low-magnification views of Nissl stained brain sections of P rats (with or without alcohol drinking) infused with aCSF or NPY showing the position of cannula tip, length of probe, and central amygdaloid target regions (WW+aCSF, Water/Water + aCSF; WW+NPY, Water/Water + NPY; WE+aCSF, Water/Ethanol + aCSF; WE+NPY, Water/Ethanol + NPY). Scale Bar = 500 μm.
Figure 2
A) Alcohol drinking (g/kg/day) patterns (7% and 9% ethanol) and effect of NPY infusion into the CeA on alcohol intake (last 3 days of 9% ethanol intake) in P rats (lower panel). No significant differences are observed in the total fluid intake (ml/day) of P rats from different groups (upper panel). Values are mean ± S.E.M. of 7 rats in each group. *Significantly different from P rats infused with aCSF (p < 0.001; repeated measures using a two-way ANOVA followed by the Tukey test). B) The effect of NPY infusion (0.5 μl of 100 pM NPY or aCSF once daily for the last 3 days of 9% ethanol voluntary intake) and alcohol consumption on the total ambulations (upper panel) and percent time spent by the P rats in each of the light and dark compartments (lower panel), during the light/dark box exploration test. Values are the mean ± S.E.M. of 7 rats per group (WW+aCSF, Water/Water + aCSF; WW+NPY, Water/Water + NPY; WE+aCSF, Water/Ethanol + aCSF; WE+NPY, Water/Ethanol + NPY). *Significantly different from the P (WW+ aCSF) rats (p < 0.001; one-way ANOVA followed by the Tukey test).
Figure 3
A) Representative photomicrographs of CREB (upper panel) and p-CREB (lower panel) gold-immunolabeling in CeA structures of P rats infused with aCSF or NPY during voluntary alcohol drinking. These photomicrographs show either CREB- or p-CREB-positive nuclei in the CeA of P rats infused with aCSF or NPY. The inset figures show the immuno-gold particles within a single nucleus (CREB, or p-CREB). Scale bar = 40 μm. B) Effect of NPY infusion into the CeA and voluntary alcohol drinking on CREB or p-CREB protein levels in CeA, MeA, and BLA of P rats. Values are mean ± S.E.M. of 7 rats per group (WW+aCSF, Water/Water + aCSF; WW+NPY, Water/Water + NPY; WE+aCSF, Water/Ethanol + aCSF; WE+NPY, Water/Ethanol + NPY). *Significantly different from the P (WW+ aCSF) rats (p < 0.001; one-way ANOVA followed by the Tukey test).
Figure 3
A) Representative photomicrographs of CREB (upper panel) and p-CREB (lower panel) gold-immunolabeling in CeA structures of P rats infused with aCSF or NPY during voluntary alcohol drinking. These photomicrographs show either CREB- or p-CREB-positive nuclei in the CeA of P rats infused with aCSF or NPY. The inset figures show the immuno-gold particles within a single nucleus (CREB, or p-CREB). Scale bar = 40 μm. B) Effect of NPY infusion into the CeA and voluntary alcohol drinking on CREB or p-CREB protein levels in CeA, MeA, and BLA of P rats. Values are mean ± S.E.M. of 7 rats per group (WW+aCSF, Water/Water + aCSF; WW+NPY, Water/Water + NPY; WE+aCSF, Water/Ethanol + aCSF; WE+NPY, Water/Ethanol + NPY). *Significantly different from the P (WW+ aCSF) rats (p < 0.001; one-way ANOVA followed by the Tukey test).
Figure 4
A) Representative photomicrographs of CaMK IV (upper panel) or PKA-Cα (lower panel) gold-immunolabeling in CeA structures of P rats infused with aCSF or NPY during voluntary alcohol drinking. The representative photomicrographs show CaMK IV or PKA-Cα-positive cells in the CeA of P rats infused with aCSF or NPY. The inset figures show the immuno-gold particles within a single nucleus for CaMK IV and within a cell body for PKA-Cα. Scale bar = 40 μm. B) Effect of NPY infusion into the CeA and voluntary alcohol drinking on CaMK IV and PKA-Cα protein levels in CeA, MeA, and BLA of P rats. Values are the mean ± S.E.M. of 5-7 rats per group (WW+aCSF, Water/Water + aCSF; WW+NPY, Water/Water + NPY; WE+aCSF, Water/Ethanol + aCSF; WE+NPY, Water/Ethanol + NPY). *Significantly different from the P (WW+ aCSF) rats (p < 0.001; one-way ANOVA followed by the Tukey test).
Figure 4
A) Representative photomicrographs of CaMK IV (upper panel) or PKA-Cα (lower panel) gold-immunolabeling in CeA structures of P rats infused with aCSF or NPY during voluntary alcohol drinking. The representative photomicrographs show CaMK IV or PKA-Cα-positive cells in the CeA of P rats infused with aCSF or NPY. The inset figures show the immuno-gold particles within a single nucleus for CaMK IV and within a cell body for PKA-Cα. Scale bar = 40 μm. B) Effect of NPY infusion into the CeA and voluntary alcohol drinking on CaMK IV and PKA-Cα protein levels in CeA, MeA, and BLA of P rats. Values are the mean ± S.E.M. of 5-7 rats per group (WW+aCSF, Water/Water + aCSF; WW+NPY, Water/Water + NPY; WE+aCSF, Water/Ethanol + aCSF; WE+NPY, Water/Ethanol + NPY). *Significantly different from the P (WW+ aCSF) rats (p < 0.001; one-way ANOVA followed by the Tukey test).
Figure 5
A) Representative photomicrographs of NPY gold-immunolabeling (upper panel) and NPY mRNA expression (in situ RT-PCR; lower panel) in the CeA of P rats with aCSF or NPY infusion during alcohol drinking. Inset figure for NPY protein shows gold particles in a cell body at high magnification (100x). Scale bar = 40 μm. B) Effect of alcohol consumption with or without central amygdaloid NPY infusion on mRNA and protein levels of NPY in the CeA, MeA and BLA structures of rats. Values are the mean ± S.E.M. derived from 5 P rats per group (WW+aCSF, Water/Water + aCSF; WW+NPY, Water/Water + NPY; WE+aCSF, Water/Ethanol + aCSF; WE+NPY, Water/Ethanol + NPY). *Significantly different from P (WW+ aCSF) rats (p < 0.01-0.001; one-way ANOVA followed by the Tukey test).
Figure 5
A) Representative photomicrographs of NPY gold-immunolabeling (upper panel) and NPY mRNA expression (in situ RT-PCR; lower panel) in the CeA of P rats with aCSF or NPY infusion during alcohol drinking. Inset figure for NPY protein shows gold particles in a cell body at high magnification (100x). Scale bar = 40 μm. B) Effect of alcohol consumption with or without central amygdaloid NPY infusion on mRNA and protein levels of NPY in the CeA, MeA and BLA structures of rats. Values are the mean ± S.E.M. derived from 5 P rats per group (WW+aCSF, Water/Water + aCSF; WW+NPY, Water/Water + NPY; WE+aCSF, Water/Ethanol + aCSF; WE+NPY, Water/Ethanol + NPY). *Significantly different from P (WW+ aCSF) rats (p < 0.01-0.001; one-way ANOVA followed by the Tukey test).
Figure 6
Representative photomicrographs showing the immunofluorescence staining for NPY (green) and CaMK IV (red) in the cells of CeA, MeA and BLA. The colocalization of the NPY and CaMK IV in cells is indicated by the yellow color development (merge). These photomicrographs show that most of the NPY-positive cells co-express CaMK IV (arrows) with a few exceptions (arrowheads). Scale bar = 20 μm.
Similar articles
- Deficits in amygdaloid cAMP-responsive element-binding protein signaling play a role in genetic predisposition to anxiety and alcoholism.
Pandey SC, Zhang H, Roy A, Xu T. Pandey SC, et al. J Clin Invest. 2005 Oct;115(10):2762-73. doi: 10.1172/JCI24381. J Clin Invest. 2005. PMID: 16200210 Free PMC article. - Effects of PKA modulation on the expression of neuropeptide Y in rat amygdaloid structures during ethanol withdrawal.
Zhang H, Pandey SC. Zhang H, et al. Peptides. 2003 Sep;24(9):1397-402. doi: 10.1016/j.peptides.2003.08.008. Peptides. 2003. PMID: 14706555 - The anxious amygdala: CREB signaling and predisposition to anxiety and alcoholism.
Wand G. Wand G. J Clin Invest. 2005 Oct;115(10):2697-9. doi: 10.1172/JCI26436. J Clin Invest. 2005. PMID: 16200206 Free PMC article. Review. - Anxiety and alcohol abuse disorders: a common role for CREB and its target, the neuropeptide Y gene.
Pandey SC. Pandey SC. Trends Pharmacol Sci. 2003 Sep;24(9):456-60. doi: 10.1016/S0165-6147(03)00226-8. Trends Pharmacol Sci. 2003. PMID: 12967770 Review.
Cited by
- Histone modifications, DNA methylation, and the epigenetic code of alcohol use disorder.
Bohnsack JP, Pandey SC. Bohnsack JP, et al. Int Rev Neurobiol. 2021;156:1-62. doi: 10.1016/bs.irn.2020.08.005. Epub 2020 Oct 17. Int Rev Neurobiol. 2021. PMID: 33461661 Free PMC article. - NPY signaling inhibits extended amygdala CRF neurons to suppress binge alcohol drinking.
Pleil KE, Rinker JA, Lowery-Gionta EG, Mazzone CM, McCall NM, Kendra AM, Olson DP, Lowell BB, Grant KA, Thiele TE, Kash TL. Pleil KE, et al. Nat Neurosci. 2015 Apr;18(4):545-52. doi: 10.1038/nn.3972. Epub 2015 Mar 9. Nat Neurosci. 2015. PMID: 25751534 Free PMC article. - Aberrant histone deacetylase2-mediated histone modifications and synaptic plasticity in the amygdala predisposes to anxiety and alcoholism.
Moonat S, Sakharkar AJ, Zhang H, Tang L, Pandey SC. Moonat S, et al. Biol Psychiatry. 2013 Apr 15;73(8):763-73. doi: 10.1016/j.biopsych.2013.01.012. Epub 2013 Feb 26. Biol Psychiatry. 2013. PMID: 23485013 Free PMC article. - Subregional Differences in Alcohol Modulation of Central Amygdala Neurocircuitry.
Melkumyan M, Silberman Y. Melkumyan M, et al. Front Mol Neurosci. 2022 Jul 5;15:888345. doi: 10.3389/fnmol.2022.888345. eCollection 2022. Front Mol Neurosci. 2022. PMID: 35866156 Free PMC article. Review. - Behavioral profiling of multiple pairs of rats selectively bred for high and low alcohol intake using the MCSF test.
Roman E, Stewart RB, Bertholomey ML, Jensen ML, Colombo G, Hyytiä P, Badia-Elder NE, Grahame NJ, Li TK, Lumeng L. Roman E, et al. Addict Biol. 2012 Jan;17(1):33-46. doi: 10.1111/j.1369-1600.2011.00327.x. Epub 2011 Apr 26. Addict Biol. 2012. PMID: 21521426 Free PMC article.
References
- Akabayashi A, Zaia CT, Gabriel SM, Silva I, Cheung WK, Leibowitz SF. Intracerebroventricular injection of dibutyryl cyclic adenosine 3′, 5′-monophosphate increases hypothalamic levels of neuropeptide Y. Brain Res. 1994;660:323–328. - PubMed
- Allen YS, Adrian TE, Allen JM, Tatemoto K, Crow TJ, Bloom SR, Polak JM. Neuropeptide Y distribution in the rat brain. Science. 1983;221:877–879. - PubMed
- Badia-Elder NE, Stewart RB, Powrozek TA, Roy KF, Murphy JM, Li T-K. Effect of neuropeptide Y(NPY) on oral ethanol intake in Wistar, alcohol-preferring (P), and -non preferring (NP) rats. Alcohol Clin Exp Res. 2001;25:386–390. - PubMed
- Badia-Elder NE, Stewart RB, Powrozek TA, Murphy JM, Li T-K. Effects of neuropeptide Y on sucrose and ethanol intake and on anxiety-like behavior in high alcohol drinking (HAD) and low alcohol drinking (LAD) rats. Alcohol Clin Exp Res. 2003;27:894–899. - PubMed
- Badia-Elder NE, Gilpin NW, Stewart RB. Neuropeptide Y modulation of ethanol intake: effects of ethanol drinking history and genetic background. Peptides. 2007;28:339–344. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- R29 AA010005/AA/NIAAA NIH HHS/United States
- R24AA015512/AA/NIAAA NIH HHS/United States
- R24 AA015512/AA/NIAAA NIH HHS/United States
- R01 AA010005-10/AA/NIAAA NIH HHS/United States
- AA-016690/AA/NIAAA NIH HHS/United States
- R01 AA010005/AA/NIAAA NIH HHS/United States
- R01 AA016690/AA/NIAAA NIH HHS/United States
- AA-015626/AA/NIAAA NIH HHS/United States
- R01 AA013341/AA/NIAAA NIH HHS/United States
- AA-013341/AA/NIAAA NIH HHS/United States
- AA-010005/AA/NIAAA NIH HHS/United States
- R21 AA015626/AA/NIAAA NIH HHS/United States
- R01 AA013341-07/AA/NIAAA NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous